
Arena Pharmaceuticals ARNA
Geschäftsbericht 2021
hinzugefügt 16.12.2023
Arena Pharmaceuticals EBITDA per Share 2011-2026 | ARNA
EBITDA per Share Jährlich Arena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.2 | -7.72 | 9.76 | -3 | -2.66 | 0.838 | -3.71 | -4.37 | -0.676 | -2.87 | -5.63 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.76 | -10.2 | -2.75 |
EBITDA per Share Vierteljährlich Arena Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -3.18 | -2.38 | -2.19 | - | -1.66 | -1.63 | -2.07 | - | -1.54 | -1.35 | 14.7 | -0.9 | -0.67 | -0.63 | -0.75 | - | -0.82 | -0.69 | -0.08 | - | -0.12 | -0.89 | -0.07 | - | -0.07 | -0.09 | -0.08 | - | -0.09 | -0.1 | -0.1 | - | -0.06 | 0.2 | -0.09 | - | -0.06 | 0.03 | -0.1 | - | -0.08 | -0.1 | -186 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.7 | -186 | -5.7 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-0.71 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.82 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
12.6 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-23.7 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-3.51 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
-0.03 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-0.03 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
0.29 | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
0.12 | $ 33.24 | -5.01 % | $ 894 M | ||
|
Forte Biosciences
FBRX
|
-5.45 | $ 22.01 | 0.02 % | $ 285 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-1.81 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-2.06 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.28 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
-5.81 | $ 93.43 | 2.75 % | $ 22.6 B | ||
|
Grifols, S.A.
GRFS
|
1.75 | $ 7.98 | -1.66 % | $ 5.42 B | ||
|
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.75 | 6.06 % | $ 466 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
-0.06 | $ 0.88 | 1.24 % | $ 147 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-3.85 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
0.34 | $ 2.84 | 8.81 % | $ 265 M | ||
|
Anika Therapeutics
ANIK
|
-0.4 | $ 14.85 | -1.17 % | $ 213 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Incyte Corporation
INCY
|
8.24 | $ 97.05 | -0.37 % | $ 18.9 B | ||
|
Aeterna Zentaris
AEZS
|
-3.37 | - | 5.93 % | $ 314 M | ||
|
Ionis Pharmaceuticals
IONS
|
-1.28 | $ 75.54 | -0.32 % | $ 12.1 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.43 | -0.29 % | $ 5.65 M | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
-1.54 | $ 1.64 | 4.14 % | $ 192 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-1.29 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 20.78 | -1.09 % | $ 2.64 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M |